Experience of using sentinel lymph node biopsy in breast cancer using ICG fluorescence in the Republic of Sakha (Yakutia)
https://doi.org/10.25789/YMJ.2025.91.11
Abstract
The aim of the study has been to investigate the possibilities of conducting and evaluating the performance of diagnostic statistical methods of ICG fluorescence for sentinel lymph node biopsy in breast cancer in the Republic of Sakha (Yakutia). The study included 223 patients diagnosed with cT1-3N0M0 , occurring in the period from 2022 to 2023. Surgical treatment for the mammary gland with sentinel lymph node biopsy using the ICG fluorescence method. As a result of the study, metastases in the lymph nodes were detected in 44 (19.73%) cases out of 223. It has been established that the use of the method of sentinel lymph node biopsy in breast cancer using ICG fluorescence of the gland allows for large-scale surgical treatment of the initial form of mammary gland cancer.
About the Authors
T. N. ZharnikovaRussian Federation
A. E. Solovyova
Russian Federation
A. K. Okoneshnikova
Russian Federation
P. V. Nikiforov
Russian Federation
T. I. Nikolaeva
Russian Federation
L. N. Afanasyeva
Russian Federation
F. G. Ivanova
Russian Federation
References
1. Sentinel lymph node biopsy in breast cancer using indocyanine green fluorescence imaging / Zikiryakhodjaev A.D., Saribekyan E.K., Bagdasarova D.V., Malishava L.E., Usov F.N., Starkova M.V. // Biomedical Photonics. 2019. Vol. 8, No. 4. P. 4–10. doi: 10.24931/2413–9432–2019–8–4–4–10
2. Biopsy of sentinel lymph nodes in early breast cancer: experience from the Research Institute of Oncology named after. N.N. Petrova / Krivorotko, P., Zernov, K., Paltuev // Issues of Oncology, 63(2), 267–273. https://doi.org/10.37469/0507-3758
3. The state of oncological care for the population of Russia in 2022. Ed. Kaprin A.D., Starinsky V.V., Shakhzadova A.O. Moscow: P.A. Herzen Medical Research Institute − branch of the National Medical Research Center of Radiology of the Ministry of Health of the Russian Federation, 2023. Ill. 254 p.
4. Akrida I, Michalopoulos NV, Lagadinou M, Papadoliopoulou M, Maroulis I, Mulita F. An Updated Review on the Emerging Role of Indocyanine Green (ICG) as a Sentinel Lymph Node Tracer in Breast Cancer. Cancers (Basel). 2023 Dec 8;15(24):5755. doi: 10.3390/cancers15245755. PMID: 38136301; PMCID: PMC10742210.
5. Alsunitan RI, Al-Saif A, Alyousef BA, Alghamdi SM, Bugshan SA. Axillary Recurrence in Breast Cancer Patients After Negative Sentinel Lymph Node Biopsy: Retrospective Cohort Study From Riyadh, Saudi Arabia. Cureus. 2021 Dec 3;13(12):e20132. doi: 10.7759/cureus.20132. PMID: 34900499; PMCID: PMC8649977.
6. Goonawardena J, Yong C, Law M. Use of indocyanine green fluorescence compared to radioisotope for sentinel lymph node biopsy in early-stage breast cancer: systematic review and meta-analysis. Am J Surg. 2020 Sep;220(3):665676. doi: 10.1016/j.amjsurg.2020.02.001. Epub 2020 Feb 7. PMID: 32115177.
7. Inoue T, Nishi T, Nakano Y, Nishimae A, Sawai Y, Yamasaki M, Inaji H. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer. Breast Cancer. 2016 Mar;23(2):295-300. doi: 10.1007/s12282-014-0573-8. Epub 2014 Oct 28. PMID: 25348937.
8. Jung SY, Han JH, Park SJ, Lee EG, Kwak J, Kim SH, Lee MH, Lee ES, Kang HS, Lee KS, Park IH, Sim SH, Jeong HJ, Kwon Y, Lee DE, Kim SK, Lee S. The Sentinel Lymph Node Biopsy Using Indocyanine Green Fluorescence Plus Radioisotope Method Compared With the Radioisotope-Only Method for Breast Cancer Patients After Neoadjuvant Chemotherapy: A Prospective, Randomized, Open-Label, Single-Center Phase 2 Trial. Ann Surg Oncol. 2019 Aug;26(8):2409-2416. doi: 10.1245/s10434-019-07400-0. Epub 2019 May 7. PMID: 31065958
9. Jung SY, Kim SK, Kim SW, Kwon Y, Lee ES, Kang HS, Ko KL, Shin KH, Lee KS, Park IH, Ro J, Jeong HJ, Joo J, Kang SH, Lee S. Comparison of sentinel lymph node biopsy guided by the multimodal method of indocyanine green fluorescence, radioisotope, and blue dye versus the radioisotope method in breast cancer: a randomized controlled trial. Ann Surg Oncol. 2014 Apr;21(4):1254-9. doi: 10.1245/s10434-0133437-0. Epub 2013 Dec 20. PMID: 24356798.
10. Kedrzycki MS, Leiloglou M, Ashrafian H, Jiwa N, Thiruchelvam PTR, Elson DS, Leff DR. Meta-analysis Comparing Fluorescence Imaging with Radioisotope and Blue Dye-Guided Sentinel Node Identification for Breast Cancer Surgery. Ann Surg Oncol. 2021 Jul;28(7):3738-3748. doi: 10.1245/s10434-020-09288-7. Epub 2020 Nov 6. PMID: 33156466; PMCID: PMC8184731.
11. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4. PMID: 33538338.
12. Thongvitokomarn S, Polchai N. Indocyanine Green Fluorescence Versus Blue Dye or Radioisotope Regarding Detection Rate of Sentinel Lymph Node Biopsy and Nodes Removed in Breast Cancer: A Systematic Review and Meta-Analysis. Asian Pac J Cancer Prev. 2020 May 1;21(5):1187-1195. doi: 10.31557/APJCP.2020.21.5.1187. PMID: 32458621; PMCID: PMC7541884.
13. Wang P, Shuai J, Leng Z, Ji Y. Meta-analysis of the application value of indocyanine green fluorescence imaging in guiding sentinel lymph node biopsy for breast cancer. Photodiagnosis Photodyn Ther. 2023 Sep; 43:103742. doi: 10.1016/j.pdpdt.2023.103742. Epub 2023 Aug 9. PMID: 37567333.
14. Wang C, Tong F, Cao Y, Liu P, Zhou B, Liu H, Cheng L, Liu M, Guo J, Xie F, Yang H, Wang S, Peng Y, Wang S. Long-term follow-up results of fluorescence and blue dye guided sentinel lymph node biopsy in early breast cancer. Breast Cancer Res Treat. 2021 Jul;188(2):361-368. doi: 10.1007/s10549-021-06196-6. Epub 2021 Mar 24. PMID: 3376
15. Xu Y, Yuan S, Chen M, Gong K, Liu Y, Li S, Xiong F, Pan Y, Cao J, Gong J, Luo N. Evaluation of indocyanine green combined with methylene blue staining in sentinel lymph node biopsy of breast cancer. Gland Surg. 2022 Sep;11(9):14891496. doi: 10.21037/gs-22-434. PMID: 36221275; PMCID: PMC9547706.
Review
For citations:
Zharnikova T.N., Solovyova A.E., Okoneshnikova A.K., Nikiforov P.V., Nikolaeva T.I., Afanasyeva L.N., Ivanova F.G. Experience of using sentinel lymph node biopsy in breast cancer using ICG fluorescence in the Republic of Sakha (Yakutia). Yakut Medical Journal. 2025;(3):48-51. https://doi.org/10.25789/YMJ.2025.91.11









